Iovance Biotherapeutics, Inc.
Overview
Iovance Biotherapeutics, Inc. is a biotechnology company focused on developing and commercializing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology. The company's therapies are designed to harness a patient's own immune system to eliminate cancer cells.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Iovance Biotherapeutics, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Adventris Pharmaceuticals
United States
Alpha Oncology Therapeutics, Inc.
USA
Aulos Bioscience, Inc.
United States
Cancer Research Innovations, Inc.
USA
Checkpoint Therapeutics, Inc.
United States
Eureka Therapeutics, Inc.
United States
Fate Therapeutics, Inc.
United States
Fred Hutchinson Cancer Center
United States
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.